Warning letterPosted February 24, 2026
FDA warning letter to ExThera Medical Corporation
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)
FDA posted a warning letter to ExThera Medical Corporation on February 24, 2026; the letter is dated February 6, 2026. Subject: Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA). Issuing office: Center for Devices and Radiological Health.
On the record
- Company
- ExThera Medical Corporation
- Subject
- Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)
- Issuing office
- Center for Devices and Radiological Health
- Letter dated
- 2026-02-06
- Posted by FDA
- 2026-02-24
- Source
- FDA warning letters ↗
CFR cited
The record cites 6 sections of 21 CFR Parts 807 and 812.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch ExThera Medical Corporation
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with ExThera Medical Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.